Trial Profile
A Phase 1, Open Label, Randomized, 2-Period, 2-Treatment, Crossover Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2019
Price :
$35
*
At a glance
- Drugs Plazomicin (Primary) ; Metformin
- Indications Bacteraemia; Gram-negative infections; Nosocomial pneumonia; Pyelonephritis; Respiratory tract infections; Urinary tract infections; Yersinia infections
- Focus Pharmacokinetics
- Sponsors Achaogen
- 01 Jan 2019 Results published in the Clinical Pharmacology in Drug Development
- 09 Oct 2017 Status changed from active, no longer recruiting to completed.
- 01 Oct 2017 Planned End Date changed from 30 Sep 2017 to 13 Oct 2017.